Cargando…

Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive

BACKGROUND: We aimed to assess the association between number of pregnancies and long‐term progression of cardiac dysfunction, arrhythmias, and event‐free survival in women with pathogenic or likely pathogenic variants of gene encoding for Lamin A/C proteins ( LMNA+). METHODS AND RESULTS: We retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Castrini, Anna I., Skjølsvik, Eystein, Estensen, Mette E., Almaas, Vibeke M., Skulstad, Helge, Lyseggen, Erik, Edvardsen, Thor, Lie, Øyvind H., Picard, Kermshlise C. I., Lakdawala, Neal K., Haugaa, Kristina H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238471/
https://www.ncbi.nlm.nih.gov/pubmed/35434999
http://dx.doi.org/10.1161/JAHA.121.024960
_version_ 1784737057249165312
author Castrini, Anna I.
Skjølsvik, Eystein
Estensen, Mette E.
Almaas, Vibeke M.
Skulstad, Helge
Lyseggen, Erik
Edvardsen, Thor
Lie, Øyvind H.
Picard, Kermshlise C. I.
Lakdawala, Neal K.
Haugaa, Kristina H.
author_facet Castrini, Anna I.
Skjølsvik, Eystein
Estensen, Mette E.
Almaas, Vibeke M.
Skulstad, Helge
Lyseggen, Erik
Edvardsen, Thor
Lie, Øyvind H.
Picard, Kermshlise C. I.
Lakdawala, Neal K.
Haugaa, Kristina H.
author_sort Castrini, Anna I.
collection PubMed
description BACKGROUND: We aimed to assess the association between number of pregnancies and long‐term progression of cardiac dysfunction, arrhythmias, and event‐free survival in women with pathogenic or likely pathogenic variants of gene encoding for Lamin A/C proteins ( LMNA+). METHODS AND RESULTS: We retrospectively included consecutive women with LMNA+ and recorded pregnancy data. We collected echocardiographic data, occurrence of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, and implantation of cardiac electronic devices (implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator). We analyzed retrospectively complications during pregnancy and the peripartum period. We included 89 women with LMNA+ (28% probands, age 41±16 years), of which 60 had experienced pregnancy. Follow‐up time was 5 [interquartile range, 3–9] years. We analyzed 452 repeated echocardiographic examinations. Number of pregnancies was not associated with increased long‐term risk of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, or implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator implantation. Women with previous pregnancy and nulliparous women had a similar annual deterioration of left ventricular ejection fraction (−0.5/year versus −0.3/year, P=0.37) and similar increase of left ventricular end‐diastolic diameter (0.1/year versus 0.2/year, P=0.09). Number of pregnancies did not decrease survival free from death, left ventricular assist device, or need for cardiac transplantation. Arrhythmias occurred during 9% of pregnancies. No increase in maternal and fetal complications was observed. CONCLUSIONS: In our cohort of women with LMNA+, pregnancy did not seem associated with long‐term adverse disease progression or event‐free survival. Likewise, women with LMNA+ generally well‐tolerated pregnancy, with a small proportion of patients experiencing arrhythmias.
format Online
Article
Text
id pubmed-9238471
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92384712022-06-30 Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive Castrini, Anna I. Skjølsvik, Eystein Estensen, Mette E. Almaas, Vibeke M. Skulstad, Helge Lyseggen, Erik Edvardsen, Thor Lie, Øyvind H. Picard, Kermshlise C. I. Lakdawala, Neal K. Haugaa, Kristina H. J Am Heart Assoc Original Research BACKGROUND: We aimed to assess the association between number of pregnancies and long‐term progression of cardiac dysfunction, arrhythmias, and event‐free survival in women with pathogenic or likely pathogenic variants of gene encoding for Lamin A/C proteins ( LMNA+). METHODS AND RESULTS: We retrospectively included consecutive women with LMNA+ and recorded pregnancy data. We collected echocardiographic data, occurrence of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, and implantation of cardiac electronic devices (implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator). We analyzed retrospectively complications during pregnancy and the peripartum period. We included 89 women with LMNA+ (28% probands, age 41±16 years), of which 60 had experienced pregnancy. Follow‐up time was 5 [interquartile range, 3–9] years. We analyzed 452 repeated echocardiographic examinations. Number of pregnancies was not associated with increased long‐term risk of atrial fibrillation, atrioventricular block, sustained ventricular arrhythmias, or implantable cardioverter defibrillator/cardiac resynchronization therapy defibrillator implantation. Women with previous pregnancy and nulliparous women had a similar annual deterioration of left ventricular ejection fraction (−0.5/year versus −0.3/year, P=0.37) and similar increase of left ventricular end‐diastolic diameter (0.1/year versus 0.2/year, P=0.09). Number of pregnancies did not decrease survival free from death, left ventricular assist device, or need for cardiac transplantation. Arrhythmias occurred during 9% of pregnancies. No increase in maternal and fetal complications was observed. CONCLUSIONS: In our cohort of women with LMNA+, pregnancy did not seem associated with long‐term adverse disease progression or event‐free survival. Likewise, women with LMNA+ generally well‐tolerated pregnancy, with a small proportion of patients experiencing arrhythmias. John Wiley and Sons Inc. 2022-04-18 /pmc/articles/PMC9238471/ /pubmed/35434999 http://dx.doi.org/10.1161/JAHA.121.024960 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Castrini, Anna I.
Skjølsvik, Eystein
Estensen, Mette E.
Almaas, Vibeke M.
Skulstad, Helge
Lyseggen, Erik
Edvardsen, Thor
Lie, Øyvind H.
Picard, Kermshlise C. I.
Lakdawala, Neal K.
Haugaa, Kristina H.
Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
title Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
title_full Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
title_fullStr Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
title_full_unstemmed Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
title_short Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
title_sort pregnancy and progression of cardiomyopathy in women with lmna genotype‐positive
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238471/
https://www.ncbi.nlm.nih.gov/pubmed/35434999
http://dx.doi.org/10.1161/JAHA.121.024960
work_keys_str_mv AT castriniannai pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT skjølsvikeystein pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT estensenmettee pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT almaasvibekem pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT skulstadhelge pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT lyseggenerik pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT edvardsenthor pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT lieøyvindh pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT picardkermshliseci pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT lakdawalanealk pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive
AT haugaakristinah pregnancyandprogressionofcardiomyopathyinwomenwithlmnagenotypepositive